Novel USP8 inhibitors were further discovered and exhibited anticancer efficiency, and treatment with the USP8 inhibitor or siRNA targeting USP8 was reported to inhibit HER-3-positive gastric cancer cell growth [14]. This evidence concerns the gene USP8 and gastric cancer.